arginyl-glycyl-aspartic acid and Acute Myelogenous Leukemia

arginyl-glycyl-aspartic acid has been researched along with Acute Myelogenous Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mooney, DJ; Shin, JW	1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and Acute Myelogenous Leukemia

Article	Year
Extracellular matrix stiffness causes systematic variations in proliferation and chemosensitivity in myeloid leukemias. Proceedings of the National Academy of Sciences of the United States of America, 2016, 10-25, Volume: 113, Issue:43 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Extracellular Matrix; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Hardness; High-Throughput Screening Assays; Humans; Hydrogels; Leukemia, Myeloid, Acute; Mice, Inbred NOD; Mice, SCID; Myeloid-Lymphoid Leukemia Protein; Oligopeptides; Oncogene Proteins, Fusion; Proto-Oncogene Proteins c-akt; raf Kinases; Signal Transduction; Xenograft Model Antitumor Assays	2016

Article

Year

Extracellular matrix stiffness causes systematic variations in proliferation and chemosensitivity in myeloid leukemias.

Proceedings of the National Academy of Sciences of the United States of America, 2016, 10-25, Volume: 113, Issue:43

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Extracellular Matrix; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Hardness; High-Throughput Screening Assays; Humans; Hydrogels; Leukemia, Myeloid, Acute; Mice, Inbred NOD; Mice, SCID; Myeloid-Lymphoid Leukemia Protein; Oligopeptides; Oncogene Proteins, Fusion; Proto-Oncogene Proteins c-akt; raf Kinases; Signal Transduction; Xenograft Model Antitumor Assays

2016